معرفی
Professor Michael Tunney is a Chair in Clinical Pharmacy and Director of Research at Queen’s University Belfast’s School of Pharmacy. His research focuses on improving detection and treatment of lung infections in cystic fibrosis (CF), bronchiectasis, and COPD. He leads a world-class lab developing diagnostic tools, novel antibiotics, and treatments targeting chronic respiratory infections. Key projects include the €50M IMI-funded iABC consortium, developing inhaled antibiotics for CF and bronchiectasis, involving industry partners like Novartis and Polyphor.
- Education: Advanced clinical pharmacy training and microbiology expertise.
- Research: Explores bacterial roles in respiratory diseases, antibiotic resistance, and low-oxygen efficacy. Uses culture and next-gen sequencing to analyze microbiomes.
- Collaborations: Works with academic and industrial partners across Europe on drug development and diagnostic innovations.
His lab’s translational work aims to translate microbiome research into clinical therapies, emphasizing anaerobic bacteria’s role in milder CF cases and biofilm inhibition strategies.
PhD opportunities focus on chronic infection detection and molecular diagnostics.
